Ellis Investment Partners’s West Pharmaceutical WST Stock Holding History

Ellis Investment Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$507K	Buy	1,413 +2	+0.1%	+$611	0.08%	167
2026 Q1	$354K	Hold	1,411	–	–	0.06%	198
2025 Q4	$388K	Hold	1,411	–	–	0.07%	185
2025 Q3	$370K	Hold	1,411	–	–	0.07%	175
2025 Q2	$309K	Hold	1,411	–	–	0.06%	190
2025 Q1	$316K	Hold	1,411	–	–	0.07%	179
2024 Q4	$462K	Hold	1,411	–	–	0.09%	149
2024 Q3	$424K	Hold	1,411	–	–	0.08%	157
2024 Q2	$465K	Hold	1,411	–	–	0.1%	149
2024 Q1	$558K	Hold	1,411	–	–	0.12%	134
2023 Q4	$497K	Hold	1,411	–	–	0.12%	134
2023 Q3	$529K	Hold	1,411	–	–	0.14%	124
2023 Q2	$540K	Hold	1,411	–	–	0.13%	130
2023 Q1	$489K	Hold	1,411	–	–	0.13%	138
2022 Q4	$332K	Hold	1,411	–	–	0.09%	160
2022 Q3	$347K	Hold	1,411	–	–	0.1%	147
2022 Q2	$426K	Hold	1,411	–	–	0.11%	142
2022 Q1	$579K	Hold	1,411	–	–	0.14%	126
2021 Q4	$661K	Hold	1,411	–	–	0.15%	114
2021 Q3	$599K	Hold	1,411	–	–	0.15%	111
2021 Q2	$506K	Hold	1,411	–	–	0.13%	124
2021 Q1	$398K	Hold	1,411	–	–	0.11%	136
2020 Q4	$400K	Hold	1,411	–	–	0.12%	127
2020 Q3	$387K	Hold	1,411	–	–	0.14%	114
2020 Q2	$317K	Hold	1,411	–	–	0.12%	126
2020 Q1	$211K	Hold	1,411	–	–	0.1%	125
2019 Q4	$214K	Hold	1,411	–	–	0.07%	147
2019 Q3	$197K	Hold	1,411	–	–	0.07%	148
2019 Q2	$175K	Buy	+1,411	New	+$167K	0.07%	161

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Ellis Investment Partners's WST Position: Q2 2026 in Review

Ellis Investment Partners increased its West Pharmaceutical (WST) stake by 0.14% in Q2 2026, buying an estimated $611 and bringing the position to 1,413 shares worth $507K. The position accounts for 0.08% of the portfolio, ranked #167.

Ellis Investment Partners first reported a position in WST in Q2 2019 and has held it in 29 quarters since. The position peaked at $661K in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Ellis Investment Partners held 1,413 shares of West Pharmaceutical worth $507K as of Q2 2026.
Ellis Investment Partners bought 2 West Pharmaceutical shares in Q2 2026, an estimated $611.
West Pharmaceutical made up 0.08% of Ellis Investment Partners's portfolio in Q2 2026, its #167 holding.
Ellis Investment Partners first reported a position in West Pharmaceutical in Q2 2019 and has held it in 29 quarters since.
Ellis Investment Partners's West Pharmaceutical position peaked at $661K in Q4 2021.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Ellis Investment Partners's 13F filing for Q2 2026, filed 5 Aug 2026.